Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Mendelsohn, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 119 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mendelsohn, J
      The epidermal growth factor receptor as a target for cancer therapy

      ENDOCRINE-RELATED CANCER
    2. Shin, DM; Donato, NJ; Perez-Soler, R; Shin, HJC; Wu, JY; Zhang, P; Lawhorn, K; Khuri, FR; Glisson, BS; Myers, J; Clayman, G; Pfister, D; Falcey, J; Waksal, H; Mendelsohn, J; Hong, WK
      Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer

      CLINICAL CANCER RESEARCH
    3. Liu, BL; Fang, M; Lu, Y; Mendelsohn, J; Fan, Z
      Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody

      ONCOGENE
    4. Mendelsohn, J
      Is arms control dead?

      ISSUES IN SCIENCE AND TECHNOLOGY
    5. Stein, MA; Mendelsohn, J; Obermeyer, WH; Amromin, J; Benca, R
      Sleep and behavior problems in school-aged children

      PEDIATRICS
    6. Mendelsohn, J; Dinney, CPN
      The Willet F. Whitmore, Jr., lectureship: Blockade of epidermal growth factor receptors as anticancer therapy

      JOURNAL OF UROLOGY
    7. Talukder, AH; Jorgensen, HF; Mandal, M; Mishra, SK; Vadlamudi, RK; Clark, BFC; Mendelsohn, J; Kumar, R
      Regulation of elongation factor-1 alpha expression by growth factors and anti-receptor blocking antibodies

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Mandal, M; Vadlamudi, R; Nguyen, D; Wang, RA; Costa, L; Bagheri-Yarmand, R; Mendelsohn, J; Kumar, R
      Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Ciardiello, F; Caputo, R; Troiani, T; Borriello, G; Kandimalla, ER; Agrawal, S; Mendelsohn, J; Bianco, AR; Tortora, G
      Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human cancer cell lines

      INTERNATIONAL JOURNAL OF CANCER
    10. Mendelsohn, J
      America, Russia, and the future of arms control

      CURRENT HISTORY
    11. Albanell, J; Codony-Servat, J; Rojo, F; Del Campo, JM; Sauleda, S; Anido, J; Raspall, G; Giralt, J; Rosello, J; Nicholson, RI; Mendelsohn, J; Baselga, J
      Activated extracellular signal-regulated kinases: Association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments

      CANCER RESEARCH
    12. Ciardiello, F; Bianco, R; Damiano, V; Fontanini, G; Caputo, R; Pomatico, G; De Placido, S; Bianco, AR; Mendelsohn, J; Tortora, G
      Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells

      CLINICAL CANCER RESEARCH
    13. Mendelsohn, J
      Blockade of receptors for growth factors: An anticancer therapy - The Fourth Annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Award Lecture

      CLINICAL CANCER RESEARCH
    14. Milas, L; Mason, K; Hunter, N; Petersen, S; Yamakawa, M; Ang, K; Mendelsohn, J; Fan, Z
      In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

      CLINICAL CANCER RESEARCH
    15. Bianco, C; Bianco, R; Tortora, G; Damiano, V; Guerrieri, P; Montemaggi, P; Mendelsohn, J; De Placido, S; Bianco, AR; Ciardiello, F
      Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide

      CLINICAL CANCER RESEARCH
    16. Mendelsohn, J; Baselga, J
      The EGF receptor family as targets for cancer therapy

      ONCOGENE
    17. Schmidt, M; Lu, Y; Liu, BL; Fang, M; Mendelsohn, J; Fan, Z
      Differential modulation of paclitaxel-mediated apoptosis by p21(Waf1) and p27(Kip1)

      ONCOGENE
    18. Baselga, J; Pfister, D; Cooper, MR; Cohen, R; Burtness, B; Bos, M; D'Andrea, G; Seidman, A; Norton, L; Gunnett, K; Falcey, J; Anderson, V; Waksal, H; Mendelsohn, J
      Phase I studies of anti-epidermal growth factor receptor chimeric antibodyC225 alone and in combination with cisplatin

      JOURNAL OF CLINICAL ONCOLOGY
    19. Fang, M; Liu, BL; Schmidt, M; Lu, Y; Mendelsohn, J; Fan, Z
      Involvement of p21(Waf1) in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells

      ANTICANCER RESEARCH
    20. Wosikowski, K; Silverman, JA; Bishop, P; Mendelsohn, J; Bates, SE
      Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    21. Mendelsohn, J
      Still bound

      BULLETIN OF THE ATOMIC SCIENTISTS
    22. Bagheri-Yarmand, R; Vadlamudi, RK; Wang, RA; Mendelsohn, J; Kumar, R
      Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin-beta 1-mediated angiogenesis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Liu, B; Fang, M; Schmidt, M; Lu, Y; Mendelsohn, J; Fan, Z
      Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity

      BRITISH JOURNAL OF CANCER
    24. Mendelsohn, J
      Use of an antibody to target geldanamycin

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    25. Schumacher, G; Fan, Z; Mendelsohn, J; Bechstein, WO; Roth, JA
      Wild-type p53 up-regulates the tumor suppressor gene p27(KIP1) which results in enhanced induction of apoptosis

      LANGENBECKS ARCHIVES OF SURGERY
    26. Ye, DW; Mendelsohn, J; Fan, Z
      Androgen and epidermal growth factor down-regulate cyclindependent kinase inhibitor p27(Kip1) and costimulate proliferation of MDA PCa 2a and MDA PCa2b prostate cancer cells

      CLINICAL CANCER RESEARCH
    27. Tortora, G; Caputo, R; Pomatico, G; Pepe, S; Bianco, AR; Agrawal, S; Mendelsohn, J; Ciardiello, F
      Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth

      CLINICAL CANCER RESEARCH
    28. Ciardiello, F; Bianco, R; Damiano, V; De Lorenzo, S; Pepe, S; De Placido, S; Fan, Z; Mendelsohn, J; Bianco, AR; Tortora, G
      Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225

      CLINICAL CANCER RESEARCH
    29. Mendelsohn, J
      Untitled

      CLINICAL CANCER RESEARCH
    30. Normanno, N; Tortora, G; De Luca, A; Pomatico, G; Casamassimi, A; Agrawal, S; Mendelsohn, J; Bianco, AR; Ciardiello, F
      Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells

      ONCOLOGY REPORTS
    31. Vadlamudi, R; Adam, L; Talukder, A; Mendelsohn, J; Kumar, R
      Serine phosphorylation of paxillin by heregulin-beta 1: role of p38 mitogen activated protein kinase

      ONCOGENE
    32. Ye, DW; Mendelsohn, J; Fan, Z
      Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition bya human-mouse chimeric anti-EGF receptor mAb C225

      ONCOGENE
    33. Vadlamudi, R; Mandal, M; Adam, L; Steinbach, G; Mendelsohn, J; Kumar, R
      Regulation of cyclooxygenase-2 pathway by HER2 receptor

      ONCOGENE
    34. Mendelsohn, J
      Atomic audit: The costs and consequences of US nuclear weapons since 1940

      ISSUES IN SCIENCE AND TECHNOLOGY
    35. Chou, JL; Fan, Z; DeBlasio, T; Koff, A; Rosen, N; Mendelsohn, J
      Constitutive overexpression of cyclin D-1 in human breast epithelial cellsdoes not prevent G(1) arrest induced by deprivation of epidermal growth factor

      BREAST CANCER RESEARCH AND TREATMENT
    36. Mendelsohn, J
      And it still won't work

      BULLETIN OF THE ATOMIC SCIENTISTS
    37. Baselga, J; Tripathy, D; Mendelsohn, J; Baughman, S; Benz, CC; Dantis, L; Sklarin, NT; Seidman, AD; Hudis, CA; Moore, J; Rosen, PP; Twaddell, T; Henderson, IC; Norton, L
      Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer

      SEMINARS IN ONCOLOGY
    38. Mendelsohn, J
      'Intimacy'

      NEW YORK TIMES BOOK REVIEW
    39. Wilson, GC; Mendelsohn, J
      Coverage of Indian Earth Sciences in international bibliographic databases: GeoRef, GeoSEARCH and MINLIB

      JOURNAL OF THE GEOLOGICAL SOCIETY OF INDIA
    40. Mendelsohn, J
      Learning electronic reference resources: A team-learning project for reference staff

      COLLEGE & RESEARCH LIBRARIES
    41. Baselga, J; Norton, L; Albanell, J; Kim, YM; Mendelsohn, J
      Recombinant humanized anti-HER2 antibody (Herceptin (TM)) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts (vol 58, pg 2825, 1998)

      CANCER RESEARCH
    42. Fan, Z; Mendelsohn, J
      Breast cancer therapy using monoclonal antibodies against epidermal growthfactor receptor and HER-2

      BREAST CANCER
    43. Mendelsohn, J
      Targeted therapy: The epidermal growth factor receptor

      PROGRESS IN ANTI-CANCER CHEMOTHERAPY, VOL II
    44. DEAN GS; PUSZTAI L; XU FJ; OBRIANT K; DESOMBRE K; CONAWAY M; BOYER CM; MENDELSOHN J; BAST RC
      CELL-SURFACE DENSITY OF P185(C-ERBB-2) DETERMINES SUSCEPTIBILITY TO ANTI-P185(C-ERBB-2)-RICIN-A CHAIN (RTA) IMMUNOTOXIN THERAPY ALONE AND IN COMBINATION WITH ANTI-P170(EGFR)-RTA IN OVARIAN-CANCER CELLS

      Clinical cancer research
    45. BROMBERG JF; FAN Z; BROWN C; MENDELSOHN J; DARNELL JE
      EPIDERMAL GROWTH FACTOR-INDUCED GROWTH-INHIBITION REQUIRES STAT1 ACTIVATION

      Cell growth & differentiation
    46. MANDAL M; ADAM L; MENDELSOHN J; KUMAR R
      NUCLEAR TARGETING OF BAX DURING APOPTOSIS IN HUMAN COLORECTAL-CANCER CELLS

      Oncogene
    47. TORTORA G; DAMIANO V; BIANCO R; PEPE S; BIANCO AR; AGRAWAL S; MENDELSOHN J; CIARDIELLO F
      SYNERGISTIC ANTITUMOR EFFECT BY NOVEL MODIFIED OLIGONUCLEOTIDES TARGETING PKAI COMBINED WITH CYTOTOXIC DRUGS OR MONOCLONAL-ANTIBODIES

      Annals of oncology
    48. MENDELSOHN J
      BLOCKADE OF SIGNAL-TRANSDUCTION AS ANTICANCER THERAPY

      Annals of oncology
    49. CIARDIELLO F; CAPUTO R; BIANCO R; POMATICO G; BIANCO AR; AGRAWAL S; MENDELSOHN J; TORTORA G
      INHIBITION OF RENAL-CANCER GROWTH BY C225 ANTIEPIDERMAL GROWTH-FACTORRECEPTOR MONOCLONAL-ANTIBODY AND PROTEIN-KINASE-A MIXED BACKBONE ANTISENSE OLIGONUCLEOTIDE

      Annals of oncology
    50. TORTORA G; CAPUTO R; DAMIANO V; PEPE S; BIANCO AR; AGRAWAL S; MENDELSOHN J; CIARDIELLO F
      SYNERGISTIC ANTITUMOR EFFECT OF NOVEL MIXED BACKBONE OLIGONUCLEOTIDESTARGETING PROTEIN-KINASE-A IN COMBINATION WITH CYTOTOXIC DRUGS OR BIOLOGICAL AGENTS

      Annals of oncology
    51. MENDELSOHN J
      PRESSURE TO DEPLOY MISSILE DEFENSES INCREASING

      Issues in science and technology
    52. BAST RC; PUSZTAI L; KERNS BJ; MACDONALD JA; JORDAN P; DALY L; BOYER CM; MENDELSOHN J; BERCHUCK A
      COEXPRESSION OF THE HER-2 GENE-PRODUCT, P185(HER-2), AND EPIDERMAL GROWTH-FACTOR RECEPTOR, P170(EGF-R), ON EPITHELIAL OVARIAN CANCERS AND NORMAL-TISSUES

      Hybridoma
    53. ADAM L; VADLAMUDI R; KONDAPAKA SB; CHERNOFF J; MENDELSOHN J; KUMAR R
      HEREGULIN REGULATES CYTOSKELETAL REORGANIZATION AND CELL-MIGRATION THROUGH THE P21-ACTIVATED KINASE-1 VIA PHOSPHATIDYLINOSITOL-3 KINASE

      The Journal of biological chemistry
    54. BANDYOPADHYAY D; MANDAL M; ADAM L; MENDELSOHN J; KUMAR R
      PHYSICAL INTERACTION BETWEEN EPIDERMAL GROWTH-FACTOR RECEPTOR AND DNA-DEPENDENT PROTEIN-KINASE IN MAMMALIAN-CELLS

      The Journal of biological chemistry
    55. KUMAR R; MANDAL M; ADAM L; BANDYOPADHYAY D; STEINBACH G; MENDELSOHN J; VADLAMUDI R
      ACTIVATION OF HER2 PATHWAY INDUCES EXPRESSION OF CYCLOOXYGENASE-2, RELEASE OF PROSTAGLANDIN-E2, AND MITOGENESIS IN HUMAN COLORECTAL-CANCER CELLS

      Gastroenterology
    56. MANDELBAUM M; EISENHOWER S; MENDELSOHN J; DEAN J
      THE CASE AGAINST NATO EXPANSION

      Current history
    57. BASELGA J; NORTON L; ALBANELL J; KIM YM; MENDELSOHN J
      RECOMBINANT HUMANIZED ANTI-HER2 ANTIBODY (HERCEPTIN(TM)) ENHANCES THEANTITUMOR-ACTIVITY OF PACLITAXEL AND DOXORUBICIN AGAINST HER2 NEU OVEREXPRESSING HUMAN BREAST-CANCER XENOGRAFTS/

      Cancer research
    58. CIARDIELLO F; CAPUTO R; BIANCO R; DAMIANO V; POMATICO G; PEPE S; BIANCO AR; AGRAWAL S; MENDELSOHN J; TORTORA G
      COOPERATIVE INHIBITION OF RENAL-CANCER GROWTH BY ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR ANTIBODY AND PROTEIN-KINASE-A ANTISENSE OLIGONUCLEOTIDE

      Journal of the National Cancer Institute
    59. MENDELSOHN J
      EPIDERMAL GROWTH-FACTOR RECEPTOR INHIBITION BY A MONOCLONAL-ANTIBODY AS ANTICANCER THERAPY

      Clinical cancer research
    60. FAN Z; SHANG BY; LU Y; CHOU JL; MENDELSOHN J
      RECIPROCAL CHANGES IN P27(KIP1) AND P21(CIP1) IN GROWTH-INHIBITION MEDIATED BY BLOCKADE OR OVERSTIMULATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS

      Clinical cancer research
    61. BOS M; MENDELSOHN J; KIM YM; ALBANELL J; FRY DW; BASELGA J
      PD153035, A TYROSINE KINASE INHIBITOR, PREVENTS EPIDERMAL GROWTH-FACTOR RECEPTOR ACTIVATION AND INHIBITS GROWTH OF CANCER-CELLS IN A RECEPTOR NUMBER-DEPENDENT MANNER

      Clinical cancer research
    62. MENDELSOHN J
      AESTHETIC PERSUASION - JAMES,HENRY, THE JEWS, AND RACE - BENJOSEPH,E

      The Henry James review
    63. MENDELSOHN J
      WRITING, CRITICISM AND THE IMAGINATION OF NATION - AMERICAN EXCEPTIONALISM AND THE EVOLUTION OF AMERICAN-STUDIES

      American studies in Scandinavia
    64. MENDELSOHN J
      PERSPECTIVES ON QUALITY OF REFERENCE SERVICE IN AN ACADEMIC-LIBRARY -A QUALITATIVE

      RQ
    65. MENDELSOHN J
      ARMS-CONTROL - THE UNFINISHED AGENDA

      Current history
    66. WANG HS; RUBIN M; FENIG E; DEBLASIO A; MENDELSOHN J; YAHALOM J; WIEDER R
      BASIC FIBROBLAST GROWTH-FACTOR CAUSES GROWTH ARREST IN MCF-7 HUMAN BREAST-CANCER CELLS WHILE INDUCING BOTH MITOGENIC AND INHIBITORY G(1) EVENTS

      Cancer research
    67. MENDELSOHN J; FAN Z
      EPIDERMAL GROWTH-FACTOR RECEPTOR FAMILY AND CHEMOSENSITIZATION

      Journal of the National Cancer Institute
    68. HU GY; LIU WB; MENDELSOHN J; ELLIS LM; RADINSKY R; ANDREEFF M; DEISSEROTH AB
      EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND HUMAN-PAPILLOMAVIRUS E6 E7 PROTEINS IN CERVICAL-CARCINOMA CELLS/

      Journal of the National Cancer Institute
    69. NORMANNO N; BIANCO C; DAMIANO V; DEANGELIS E; SELVAM MP; GRASSI M; MAGLIULO G; TORTORA G; BIANCO AR; MENDELSOHN J; SALOMON DS; CIARDIELLO F
      GROWTH-INHIBITION OF HUMAN COLON-CARCINOMA CELLS BY COMBINATIONS OF ANTIEPIDERMAL GROWTH FACTOR-RELATED GROWTH-FACTOR ANTISENSE OLIGONUCLEOTIDES

      Clinical cancer research
    70. PREWETT M; ROCKWELL P; ROCKWELL RF; GIORGIO NA; MENDELSOHN J; SCHER HI; GOLDSTEIN NI
      THE BIOLOGIC EFFECTS OF C225, A CHIMERIC MONOCLONAL-ANTIBODY TO THE EGFR, ON HUMAN PROSTATE CARCINOMA

      Journal of immunotherapy with emphasis on tumor immunology
    71. SOOS TJ; KIYOKAWA H; YAN JS; RUBIN MS; GIORDANO A; DEBLASIO A; BOTTEGA S; WONG BM; MENDELSOHN J; KOFF A
      FORMATION OF P27-CDK COMPLEXES DURING THE HUMAN MITOTIC CELL-CYCLE

      Cell growth & differentiation
    72. WU XP; RUBIN M; FAN Z; DEBLASIO T; SOOS T; KOFF A; MENDELSOHN J
      INVOLVEMENT OF P27(KIP1) IN G(1) ARREST MEDIATED BY AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY

      Oncogene
    73. BASELGA J; TRIPATHY D; MENDELSOHN J; BAUGHMAN S; BENZ CC; DANTIS L; SKLARIN NT; SEIDMAN AD; HUDIS CA; MOORE J; ROSEN PP; TWADDELL T; HENDERSON IC; NORTON L
      PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/

      Journal of clinical oncology
    74. MENDELSOHN J
      A 10TH INNING FOR STAR-WARS - THE ABM TREATY IS IN DANGER

      Bulletin of the atomic scientists
    75. SLOVIN SF; LIVINGSTON PO; ROSEN N; SEPPLORENZINO L; KELLY WK; MENDELSOHN J; SCHER HI
      TARGETED THERAPY FOR PROSTATE-CANCER - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER APPROACH

      Seminars in oncology
    76. BECKER JC; PANCOOK JD; GILLIES SD; MENDELSOHN J; REISFELD RA
      ERADICATION OF HUMAN HEPATIC AND PULMONARY MELANOMA METASTASES IN SCID MICE BY ANTIBODY-INTERLEUKIN-2 FUSION PROTEINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    77. BASELGA J; MENDELSOHN J; KIM YM; PANDIELLA A
      AUTOCRINE REGULATION OF MEMBRANE TRANSFORMING GROWTH-FACTOR-ALPHA CLEAVAGE

      The Journal of biological chemistry
    78. REISFELD RA; GILLIES SD; MENDELSOHN J; VARKI NM; BECKER JC
      INVOLVEMENT OF B-LYMPHOCYTES IN THE GROWTH-INHIBITION OF HUMAN PULMONARY MELANOMA METASTASES IN ATHYMIC NU NU MICE BY IN ANTIBODY-LYMPHOTOXIN FUSION PROTEIN/

      Cancer research
    79. PENG D; FAN Z; LU Y; DEBLASIO T; SCHER H; MENDELSOHN J
      ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY-225 UP-REGULATES P27(KIP1) AND INDUCES G(1) ARREST IN PROSTATIC-CANCER CELL-LINE DU145

      Cancer research
    80. CIARDIELLO F; DAMIANO V; BIANCO R; BIANCO C; FONTANINI G; DELAURENTIIS M; DEPLACIDO S; MENDELSOHN J; BIANCO AR; TORTORA G
      ANTITUMOR-ACTIVITY OF COMBINED BLOCKADE OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND PROTEIN-KINASE-A

      Journal of the National Cancer Institute
    81. KATZENELLENBOGEN JA; COLEMAN RE; HAWKINS RA; KROHN KA; LARSON SM; MENDELSOHN J; OSBORNE CK; PIWNICAWORMS D; REBA RC; SIEGEL BA; WELCH MJ; SHTERN F
      TUMOR RECEPTOR IMAGING - PROCEEDINGS OF THE NATIONAL-CANCER-INSTITUTEWORKSHOP, REVIEW OF CURRENT WORK, AND PROSPECTIVE FOR FURTHER INVESTIGATIONS

      Clinical cancer research
    82. MENDELSOHN J
      UNTITLED

      Clinical cancer research
    83. SCHER HI; SARKIS A; REUTER V; COHEN D; NETTO G; PETRYLAK D; LIANES P; FUKS Z; MENDELSOHN J; CORDONCARDO C
      CHANGING PATTERN OF EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH-FACTOR-ALPHA IN THE PROGRESSION OF PROSTATICNEOPLASMS

      Clinical cancer research
    84. CIARDIELLO F; DAMIANO V; BIANCO C; DIISERNIA G; RUGGIERO A; CARAGLIA M; TAGLIAFERRI P; BASELGA J; MENDELSOHN J; BIANCO AR; TORTORA G
      COOPERATIVE ANTIPROLIFERATIVE EFFECTS OF 8-CHLORO-CYCLIC AMP AND 528 ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY ON HUMAN CANCER-CELLS

      Clinical cancer research
    85. GOLDSTEIN NI; PREWETT M; ZUKLYS K; ROCKWELL P; MENDELSOHN J
      BIOLOGICAL EFFICACY OF A CHIMERIC ANTIBODY TO THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN A HUMAN TUMOR XENOGRAFT MODEL

      Clinical cancer research
    86. MENDELSOHN J
      INAUGURAL EDITORIAL

      Clinical cancer research
    87. MENDELSOHN J
      STAR-WARS REDUX

      Issues in science and technology
    88. WOO P; MENDELSOHN J; HUMPHREY D
      RHEUMATOID NODULES OF THE LARYNX

      Otolaryngology and head and neck surgery
    89. KORUTLA L; CHEUNG JY; MENDELSOHN J; KUMAR R
      INHIBITION OF LIGAND-INDUCED ACTIVATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE PHOSPHORYLATION BY CURCUMIN

      Carcinogenesis
    90. MENDELSOHN J
      STIFF ARMING RUSSIA

      Bulletin of the atomic scientists
    91. WU XP; FAN Z; MASUI H; ROSEN N; MENDELSOHN J
      APOPTOSIS INDUCED BY AN ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY IN A HUMAN COLORECTAL-CARCINOMA CELL CINE AND ITS DELAY BYINSULIN

      The Journal of clinical investigation
    92. BENTEL JM; LEBWOHL DE; CULLEN KJ; RUBIN MS; ROSEN N; MENDELSOHN J; MILLER WH
      INSULIN-LIKE GROWTH-FACTORS MODULATE THE GROWTH-INHIBITORY EFFECTS OFRETINOIC ACID ON MCF-7 BREAST-CANCER CELLS

      Journal of cellular physiology
    93. FAN Z; LU Y; WU XP; DEBLASIO A; KOFF A; MENDELSOHN J
      PROLONGED INDUCTION OF P21(CIP1 WAF1)/CDK2/PCNA COMPLEX BY EPIDERMAL GROWTH-FACTOR RECEPTOR ACTIVATION MEDIATES LIGAND-INDUCED A431 CELL-GROWTH INHIBITION/

      The Journal of cell biology
    94. WELS W; BEERLI R; HELLMANN P; SCHMIDT M; MARTE BM; KORNILOVA ES; HEKELE A; MENDELSOHN J; GRONER B; HYNES NE
      EGF RECEPTOR AND P185(ERB-2)-SPECIFIC SINGLE-CHAIN ANTIBODY TOXINS DIFFER IN THEIR CELL-KILLING ACTIVITY ON TUMOR-CELLS EXPRESSING BOTH RECEPTOR PROTEINS

      International journal of cancer
    95. BASELGA J; NORTON L; COPLAN K; SHALABY R; MENDELSOHN J
      ANTI-GROWTH FACTOR-RECEPTOR MONOCLONAL-ANTIBODIES ENHANCE THE ANTITUMOR EFFECTS OF PACLITAXEL IN BREAST-CANCER XENOGRAFTS

      Journal of cellular biochemistry
    96. KUMAR R; MENDELSOHN J
      REDUCED EXPRESSION OF C-ERBB2 GENE-PRODUCT IN HUMAN MAMMARY-CARCINOMASK-BR-3 CELLS TREATED WITH INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA

      Anticancer research
    97. STURGIS EM; SACKS PG; MASUI H; MENDELSOHN J; SCHANTZ SP
      EFFECTS OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR ANTIBODY-528 ON THE PROLIFERATION AND DIFFERENTIATION OF HEAD-AND-NECK-CANCER

      Otolaryngology and head and neck surgery
    98. BASELGA J; MENDELSOHN J
      THE EPIDERMAL GROWTH-FACTOR RECEPTOR AS A TARGET FOR THERAPY IN BREAST-CARCINOMA

      Breast cancer research and treatment
    99. BASELGA J; MENDELSOHN J
      RECEPTOR BLOCKADE WITH MONOCLONAL-ANTIBODIES AS ANTICANCER THERAPY

      Pharmacology & therapeutics
    100. BASELGA J; MENDELSOHN J
      RECEPTOR BLOCKADE WITH MONOCLONAL-ANTIBODIES AS ANTICANCER THERAPY

      Pharmacology & therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 20:46:44